HomeHealthThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment...

ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Published on

<br /> ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference<br />

PR Newswire



RANCHO CORDOVA, Calif.


,


Sept. 7, 2022


/PRNewswire/ — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that

Chris Xu

, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 24

th

Annual Global Investment Conference, taking place

September 12-14, 2022

.  Details of Dr. Xu’s in-person presentation are as follows:


Date

:

Wednesday, September 14, 2022



Time

:

12:00pm Eastern Time

Dr. Xu will also host in-person and virtual one-on-one meetings during the event. Institutional investors who are registered for the conference can log into

www.hcwevents.com

to request a meeting with the company

A live webcast of the presentation will be available on the ThermoGenesis website at:

https://ThermoGenesis.com/investors/news-and-events/events-webcasts

.

An archived replay will be available for a period of 90 days after the conference.


About ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit:

www.thermogenesis.com

.


Company Contact:



Wendy Samford


916-858-5191


[email protected]


Investor Contact:


Paula Schwartz, Rx Communications

917-322-2216


[email protected]

Cision
View original content:

https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference-301619020.html

SOURCE ThermoGenesis Holdings, Inc.

rt ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Featured image: Megapixl © Leowolfert

Disclaimer

Latest News

Aetna 2023 Medicare plans put money back in members’ pockets

Aetna 2023 Medicare plans put money back in...

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Fezolinetant

European Medicines Agency Accepts Astellas' Marketing Authorization Application...

Biogen Announced EMA Filing Acceptance of BIIB800, A Biosimilar Candidate Referencing RoACTEMRA® (tocilizumab)

CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- ...

Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement

Q&M Group awards 7 dentists with Performance Shares,12-year...

More like this

Numinus to Participate in the Cantor Neurology and Psychiatry Conference on October 6-7, 2022

VANCOUVER, BC, Sept. 29, 2022 - Numinus Wellness Inc. ("Numinus" or the "Company")(TSX:NUMI)(OTCQX:NUMIF), a mental...

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly...

AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn’s Disease and Ulcerative Colitis at the UEG Week 2022

AbbVie Highlights Robust Gastroenterology Portfolio with New Data...

Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

CHICAGO, IL / ACCESSWIRE / September 28, 2022 / Cosmos Holdings d/b/a Cosmos Health,...

Moderna Creates New Executive Committee Role Ahead of New Product Launches

Juan Andres Appointed to President, Strategic Partnerships and Enterprise ExpansionJerh Collins Joins Moderna as...